AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Newron Pharmaceuticals S.p.A.

CHF 10.8 -$14.70 (-57.65%)
SIX · 15 Sep 2026 15:30 UTC
Previous Close
CHF 11.06
Day Range
CHF 10.72CHF 11.12
Year Range
CHF 8.83CHF 31.85
Market Cap
224.7M
AVG Volume
52.12K
Trailing/Forward PE
-16.97/81.68
PEG ratio
0.16
Dividend Yield
-
Next Earnings Date
2026-09-22
Primary Exchange
Swiss ExchangeCH
Revenue (EUR)
020M40M60M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Revenue (EUR) by quarter
PeriodRevenue (EUR)
25 Q47.24M
25 Q211.9M
24 Q447.98M
24 Q23.41M
23 Q43.56M
23 Q25.49M
22 Q43.26M
22 Q22.83M
21 Q43.09M
21 Q22.67M
Net Income (EUR)
-20M-10M010M20M30M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Net Income (EUR) by quarter
PeriodNet Income (EUR)
25 Q4-13.19M
25 Q2-73K
24 Q425.4M
24 Q2-9.56M
23 Q4-9.27M
23 Q2-6.95M
22 Q4-8.86M
22 Q2-8.64M
21 Q4-5.84M
21 Q2-9.06M
Operating Income (EUR)
-20M020M40M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
25 Q4-6.05M
25 Q21.34M
24 Q433.86M
24 Q2-7.68M
23 Q4-7.32M
23 Q2-4.31M
22 Q4-6.85M
22 Q2-6.45M
21 Q4-4.47M
21 Q2-7.89M
EBITDA (EUR)
-20M020M40M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
25 Q4-5.96M
25 Q21.43M
24 Q433.53M
24 Q2-7.59M
23 Q4-7.29M
23 Q2-4.2M
22 Q4-6.75M
22 Q2-6.35M
21 Q4-4.37M
21 Q2-7.78M
Cash Flows (EUR)
-20M020M40M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Cash Flows (EUR) by quarter
PeriodCash Flows (EUR)
25 Q4-1.34M
25 Q233.32M
24 Q4-8.79M
24 Q2-8.84M
23 Q4-4.54M
23 Q2-5.61M
22 Q4-5.47M
22 Q2-5.64M
21 Q4-2.71M
21 Q2-8.76M
EPS (EUR)
-101221 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW EPS (EUR) by quarter
PeriodEPS (EUR)
25 Q4-0.67
25 Q2-0
24 Q41.36
24 Q2-0.51
23 Q4-0.52
23 Q2-0.39
22 Q4-0.5
22 Q2-0.48
21 Q4-0.33
21 Q2-0.51
Expenses (EUR)
05M10M15MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Expenses (EUR) by quarter
PeriodExpenses (EUR)
25 Q49.42M
25 Q210.71M
24 Q410.05M
24 Q211.1M
23 Q410.94M
23 Q29.81M
22 Q410.17M
22 Q29.29M
21 Q47.34M
21 Q210.83M
Cash & Debt (EUR)
020M40M60MCashLong Term DebtShort Term Debt21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
25 Q428.85M
25 Q243.2M
24 Q49.83M
24 Q212.19M
23 Q412.6M
23 Q217.14M
22 Q422.77M
22 Q228.36M
21 Q434.59M
21 Q221.91M
Debt ratios
-202421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Debt ratios by quarter
PeriodDebt ratios
25 Q40.43
25 Q20.47
24 Q42.81
24 Q2-1.42
23 Q4-1.46
23 Q2-1.38
22 Q4-0.91
22 Q2-0.61
21 Q4-0.28
21 Q2-0.16
Margins
0%25%50%75%100%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Margins by quarter
PeriodMargins
25 Q499.84%
25 Q2100%
24 Q4100%
24 Q2100%
23 Q4100%
23 Q2100%
22 Q4100%
22 Q2100%
21 Q4100%
21 Q2100%
Return on Capital
-500%0%500%1000%1500%2000%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Return on Capital by quarter
PeriodReturn on Capital
25 Q4118.53%
25 Q2-4.61%
24 Q41742.11%
24 Q231%
23 Q431.01%
23 Q233.16%
22 Q463.13%
22 Q2164.65%
21 Q4-187.9%
21 Q2-104.27%
Shares Outstanding
05M10M15M20M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Shares Outstanding by quarter
PeriodShares Outstanding
25 Q419.96M
25 Q219.96M
24 Q418.56M
24 Q218.56M
23 Q417.85M
23 Q217.85M
22 Q417.85M
22 Q217.85M
21 Q417.85M
21 Q217.85M
Book Value Per Share (EUR)
-2-10121 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
25 Q4-0.56
25 Q20.08
24 Q40.08
24 Q2-1.66
23 Q4-1.68
23 Q2-1.17
22 Q4-0.79
22 Q2-0.29
21 Q40.17
21 Q20.49
Total Assets (EUR)
020M40M60M80M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
NWRN.SW Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
25 Q440.02M
25 Q261.39M
24 Q463.91M
24 Q224.94M
23 Q425.87M
23 Q231.49M
22 Q437.2M
22 Q243.54M
21 Q450.49M
21 Q239.89M
PE Ratio
255075100125150med 90.3Oct 25Dec 25Feb 26Apr 26May 26Jul 26Sep 26
NWRN.SW PE Ratio by quarter
PeriodPE Ratio
Sep 2690.3
Sep 2692.57
Sep 2698.74
Aug 26101.91
Aug 26103.6
Aug 26102.13
Aug 26101.19
Jul 2696.89
Jul 2698.74
Jul 2696.99
Jul 2698.91
Jul 26102.7
Jun 26106.07
Jun 26101.98
Jun 26101.16
Jun 26102.9
May 26115.75
May 26119.22
May 26120.2
May 26114.99
Apr 26120.55
Apr 26131.01
Apr 26138.21
Apr 26125.75
Apr 26127.41
Mar 2649.56
Mar 2649.24
Mar 2655.83
Mar 2660.18
Feb 2662.91
Feb 2664.81
Feb 2667.13
Feb 2664.05
Jan 2665.37
Jan 2671.58
Jan 2681.55
Jan 26100.23
Dec 2578.8
Dec 2578.24
Dec 2575.55
Dec 2566.28
Dec 2559.99
Nov 2558.38
Nov 2550.6
Nov 2550.41
Nov 2546.9
Oct 2547.65
Oct 2547.44
Oct 2544.61
Oct 2550.62
Oct 2542.67
Free Cash Flow Yield
-30%-20%-10%0%10%med 1.91%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NWRN.SW Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 266.16%
Sep 266%
Sep 265.63%
Aug 265.45%
Aug 265.36%
Aug 265.44%
Aug 265.49%
Jul 265.74%
Jul 265.63%
Jul 265.73%
Jul 265.62%
Jul 265.41%
Jun 265.24%
Jun 265.45%
Jun 265.49%
Jun 265.4%
May 264.8%
May 264.66%
May 264.62%
May 264.83%
Apr 264.61%
Apr 264.24%
Apr 264.02%
Apr 264.42%
Apr 264.36%
Mar 263.46%
Mar 263.49%
Mar 263.08%
Mar 262.85%
Feb 262.73%
Feb 262.65%
Feb 262.56%
Feb 262.68%
Jan 262.63%
Jan 262.4%
Jan 262.11%
Jan 261.71%
Dec 252.18%
Dec 252.19%
Dec 252.27%
Dec 252.59%
Dec 252.86%
Nov 252.94%
Nov 253.39%
Nov 253.41%
Nov 253.66%
Oct 253.6%
Oct 253.62%
Oct 253.85%
Oct 253.39%
Oct 254.02%
Sep 25-13.32%
Sep 25-13.06%
Sep 25-15.61%
Sep 25-15.03%
Aug 25-16.51%
Aug 25-18.42%
Aug 25-20.15%
Aug 25-18.83%
Jul 25-20.14%
Jul 25-19.82%
Jul 25-20.53%
Jul 25-19.42%
Jul 25-20.01%
Jun 25-20.46%
Jun 25-19.83%
Jun 25-19.33%
Jun 25-18.2%
May 25-19.07%
May 25-18.92%
May 25-17.79%
May 25-16.97%
May 25-17.46%
Apr 25-19.73%
Apr 25-21.57%
Apr 25-22.96%
Apr 25-22.93%
Mar 25-15.75%
Mar 25-14.95%
Mar 25-15.07%
Mar 25-14.19%
Feb 25-12.46%
Feb 25-11.98%
Feb 25-12.28%
Feb 25-12.73%
Jan 25-13.14%
Jan 25-13.26%
Jan 25-13.91%
Jan 25-13.92%
Jan 25-13.99%
Dec 24-14.03%
Dec 24-15.24%
Dec 24-13.42%
Dec 24-16.09%
Nov 24-15.85%
Nov 24-17.04%
Nov 24-16.89%
Nov 24-15.65%
Nov 24-15.14%
Oct 24-14.17%
Price to Sales
051015med 4.58Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NWRN.SW Price to Sales by quarter
PeriodPrice to Sales
Sep 263.31
Sep 263.39
Sep 263.62
Aug 263.73
Aug 263.79
Aug 263.74
Aug 263.71
Jul 263.55
Jul 263.62
Jul 263.55
Jul 263.62
Jul 263.76
Jun 263.88
Jun 263.73
Jun 263.7
Jun 263.77
May 264.24
May 264.37
May 264.4
May 264.21
Apr 264.41
Apr 264.8
Apr 265.06
Apr 264.6
Apr 264.67
Mar 264.82
Mar 264.78
Mar 265.43
Mar 265.85
Feb 266.11
Feb 266.3
Feb 266.52
Feb 266.22
Jan 266.35
Jan 266.96
Jan 267.92
Jan 269.74
Dec 257.66
Dec 257.6
Dec 257.34
Dec 256.44
Dec 255.83
Nov 255.67
Nov 254.92
Nov 254.9
Nov 254.56
Oct 254.63
Oct 254.61
Oct 254.33
Oct 254.92
Oct 254.15
Sep 253.45
Sep 253.52
Sep 252.94
Sep 253.06
Aug 252.78
Aug 252.5
Aug 252.28
Aug 252.44
Jul 252.28
Jul 252.32
Jul 252.24
Jul 252.37
Jul 252.3
Jun 252.25
Jun 252.32
Jun 252.38
Jun 252.53
May 252.41
May 252.43
May 252.58
May 252.71
May 252.63
Apr 252.33
Apr 252.13
Apr 252
Apr 252
Mar 259.87
Mar 2510.4
Mar 2510.32
Mar 2510.96
Feb 2512.48
Feb 2512.98
Feb 2512.66
Feb 2512.22
Jan 2511.83
Jan 2511.72
Jan 2511.18
Jan 2511.17
Jan 2511.11
Dec 2411.08
Dec 2410.2
Dec 2411.59
Dec 249.67
Nov 249.81
Nov 249.13
Nov 249.21
Nov 249.94
Nov 2410.27
Oct 2410.98
EV/EBITDA
10203040med 14.31Jun 25Aug 25Nov 25Jan 26Apr 26Jul 26Sep 26
NWRN.SW EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2611.33
Sep 2611.6
Sep 2612.35
Aug 2612.73
Aug 2612.93
Aug 2612.75
Aug 2612.64
Jul 2612.12
Jul 2612.35
Jul 2612.14
Jul 2612.37
Jul 2612.82
Jun 2613.23
Jun 2612.74
Jun 2612.64
Jun 2612.85
May 2614.4
May 2614.82
May 2614.93
May 2614.31
Apr 2614.98
Apr 2616.24
Apr 2617.11
Apr 2615.6
Apr 2615.81
Mar 2616.5
Mar 2616.39
Mar 2618.53
Mar 2619.93
Feb 2620.82
Feb 2621.43
Feb 2622.18
Feb 2621.19
Jan 2621.61
Jan 2623.62
Jan 2626.85
Jan 2632.89
Dec 2525.96
Dec 2525.78
Dec 2524.91
Dec 2521.91
Dec 2519.87
Nov 2519.35
Nov 2516.83
Nov 2516.77
Nov 2515.64
Oct 2515.88
Oct 2515.81
Oct 2514.9
Oct 2516.84
Oct 2514.27
Sep 2517.24
Sep 2517.54
Sep 2515.13
Sep 2515.61
Aug 2514.46
Aug 2513.25
Aug 2512.36
Aug 2513.02
Jul 2512.36
Jul 2512.51
Jul 2512.18
Jul 2512.71
Jul 2512.42
Jun 2512.21
Jun 2512.51
Jun 2512.76
Jun 2513.38
May 2512.89
May 2512.98
May 2513.62
May 2514.14
May 2513.83
Apr 2512.56
Apr 2511.73
Apr 2511.19
Apr 2511.2
Price/Operating Cashflow
0204060med 24.76Oct 25Dec 25Feb 26Apr 26May 26Jul 26Sep 26
NWRN.SW Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2616.18
Sep 2616.59
Sep 2617.69
Aug 2618.26
Aug 2618.56
Aug 2618.3
Aug 2618.13
Jul 2617.36
Jul 2617.69
Jul 2617.38
Jul 2617.72
Jul 2618.4
Jun 2619
Jun 2618.27
Jun 2618.12
Jun 2618.44
May 2620.74
May 2621.36
May 2621.54
May 2620.6
Apr 2621.6
Apr 2623.47
Apr 2624.76
Apr 2622.53
Apr 2622.83
Mar 2628.74
Mar 2628.55
Mar 2632.38
Mar 2634.9
Feb 2636.48
Feb 2637.58
Feb 2638.93
Feb 2637.14
Jan 2637.91
Jan 2641.51
Jan 2647.29
Jan 2658.12
Dec 2545.7
Dec 2545.37
Dec 2543.81
Dec 2538.43
Dec 2534.79
Nov 2533.85
Nov 2529.34
Nov 2529.23
Nov 2527.2
Oct 2527.63
Oct 2527.51
Oct 2525.87
Oct 2529.35
Oct 2524.74
Price to Book
0200400600med 85.7Dec 21Apr 22Jul 22May 25Aug 25Dec 25Mar 26
NWRN.SW Price to Book by quarter
PeriodPrice to Book
Mar 26203.5
Mar 26202.18
Mar 26229.27
Mar 26247.11
Feb 26258.32
Feb 26266.11
Feb 26275.65
Feb 26263.02
Jan 26268.42
Jan 26293.93
Jan 26334.86
Jan 26411.57
Dec 25323.56
Dec 25321.27
Dec 25310.23
Dec 25272.14
Dec 25246.32
Nov 25239.72
Nov 25207.77
Nov 25206.98
Nov 25192.59
Oct 25195.66
Oct 25194.8
Oct 25183.18
Oct 25207.85
Oct 25175.19
Sep 25142.98
Sep 25145.89
Sep 25122.08
Sep 25126.75
Aug 25115.41
Aug 25103.45
Aug 2594.57
Aug 25101.16
Jul 2594.62
Jul 2596.1
Jul 2592.82
Jul 2598.11
Jul 2595.23
Jun 2593.12
Jun 2596.1
Jun 2598.58
Jun 25104.7
May 2599.89
May 25100.71
May 25107.09
May 25112.24
May 25109.13
Apr 2596.54
Apr 2588.31
Apr 2582.97
Apr 2583.08
Sep 228.04
Sep 228.5
Sep 228.22
Sep 228.36
Aug 228.59
Aug 228.59
Aug 228.57
Aug 228.5
Jul 228.44
Jul 228.42
Jul 228.05
Jul 228.58
Jul 228.33
Jun 228.69
Jun 228.18
Jun 229.01
Jun 228.07
May 228.05
May 228.09
May 227.6
May 227.71
Apr 228.17
Apr 227.78
Apr 227.5
Apr 227.8
Apr 227.3
Mar 222.57
Mar 222.51
Mar 222.6
Mar 222.66
Feb 222.85
Feb 222.76
Feb 222.9
Feb 222.73
Jan 222.96
Jan 223.04
Jan 222.95
Jan 223.01
Dec 213.21
Dec 213.11
Dec 212.97
Dec 213.06
Dec 213.42
Nov 213.53
Nov 213.63
Nov 213.89
Nov 214.01
Oct 213.59
Newron Pharmaceuticals S.p.A.
NWRN.SW
Stockpicker

Video analysis: NWRN.SW

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.